Allergy and Immunology, Allergy · San Juan, PR
NPI
1023166055
Since 2007
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
317 Ave Manuel Domenech
San Juan, PR, 00918
Phone (787) 764-5715
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
2,342 services
Medicare patients, 2024
65
Average age 74
Drug cost, 2024
$4.5M
1,801 prescriptions
Company payments, 2025
$40K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafael H Zaragoza Urdaz was code 95004 (test - miscellaneous), 1,060 times for 17 patients. In total Rafael H Zaragoza Urdaz billed 2,342 services in 18 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,060 | 17 | $2.77 | $2,935 |
| 95165 Treatment - Miscellaneous | Office | 847 | 33 | $10.12 | $8,571 |
| 95115 Treatment - Miscellaneous | Office | 87 | 12 | $6.39 | $556 |
| 99214 Office E&M - Established | Office | 76 | 51 | $87.12 | $6,621 |
| 95018 Test - Miscellaneous | Office | 64 | 16 | $13.06 | $836 |
| 99213 Office E&M - Established | Office | 16 | 16 | $64.07 | $1,025 |
By year: 2022 $36K for 2,454 services; 2023 $24K for 1,813 services; 2024 $23K for 2,342 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rafael H Zaragoza Urdaz prescribed most often to Medicare patients was Levocetirizine Dihydrochloride, with 236 prescriptions and refills. In total Rafael H Zaragoza Urdaz wrote 1,801 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride Generic | 236 | 260 | 84 | $2,694 |
| Methylprednisolone Generic | 194 | 195 | 94 | $3,778 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 120 | 134 | 53 | $12K |
| Takhzyro Lanadelumab-Flyo | 74 | 74 | Under 11 | $3.0M |
| Montelukast Sodium Generic | 67 | 92 | 25 | $764 |
| Desloratadine Generic | 66 | 72 | 17 | $1,560 |
| Albuterol Sulfate Generic | 64 | 64 | 46 | $465 |
| Dupixent Syringe Dupilumab | 46 | 46 | Under 11 | $175K |
| Clobetasol Propionate Generic | 46 | 46 | 22 | $3,474 |
| Prednisolone Sodium Phosphate Generic | 44 | 44 | 34 | $929 |
| Fluticasone Propionate Generic | 36 | 41 | 13 | $612 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 33 | 33 | Under 11 | $22K |
| Azelastine Hcl Generic | 33 | 45 | 18 | $841 |
| Meloxicam Generic | 31 | 31 | Under 11 | $122 |
| Firazyr Icatibant Acetate | 29 | 29 | Under 11 | $965K |
Brand drugs: - claims; generic drugs: 1,382 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael H Zaragoza Urdaz $40K ($40K in general payments such as food, travel and fees) from 12 companies. The largest payer was Pharming Healthcare, Inc. with $13K.
| Company | Payments | Amount |
|---|---|---|
| Pharming Healthcare, Inc. | 13 | $13K |
| BioCryst US Sales Co., LLC | 43 | $12K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 19 | $10K |
| BioCryst Pharmaceuticals, Inc. BCRX | 5 | $3,674 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $187 |
| Genentech, Inc. ROG.SW | 3 | $163 |
| Genzyme Corporation SNY | 4 | $97.26 |
| Pfizer Inc. PFE | 1 | $93.6 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $77.29 |
| Pbg Puerto Rico LLC | 4 | $59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.